Hims & Hers Health (NYSE:HIMS) Coverage Initiated at BTIG Research

BTIG Research assumed coverage on shares of Hims & Hers Health (NYSE:HIMS) in a research report sent to investors on Tuesday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $35.00 target price on the stock.

Several other analysts have also commented on the company. Needham & Company LLC increased their price objective on Hims & Hers Health from $28.00 to $31.00 and gave the company a “buy” rating in a report on Monday. Piper Sandler increased their price objective on Hims & Hers Health from $21.00 to $24.00 and gave the company a “neutral” rating in a report on Monday. Canaccord Genuity Group increased their price objective on Hims & Hers Health from $28.00 to $38.00 and gave the company a “buy” rating in a report on Monday, December 2nd. Bank of America lowered Hims & Hers Health from a “buy” rating to an “underperform” rating and reduced their target price for the stock from $32.00 to $18.00 in a research note on Thursday, November 14th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on Hims & Hers Health from $23.00 to $27.00 and gave the stock a “hold” rating in a research report on Wednesday, November 6th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and eight have given a buy rating to the stock. According to MarketBeat, Hims & Hers Health has an average rating of “Hold” and a consensus price target of $24.80.

Hims & Hers Health Stock Performance

HIMS opened at $25.74 on Tuesday. The stock has a market cap of $5.62 billion, a price-to-earnings ratio of 58.50 and a beta of 1.31. The stock’s 50 day moving average price is $27.11 and its 200-day moving average price is $21.62. Hims & Hers Health has a one year low of $8.14 and a one year high of $35.02.

Hims & Hers Health (NYSE:HIMS) last announced its quarterly earnings data on Monday, November 4th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.26. Hims & Hers Health had a return on equity of 10.97% and a net margin of 8.19%. The company had revenue of $401.56 million for the quarter, compared to analysts’ expectations of $382.20 million. During the same quarter in the prior year, the firm earned ($0.04) earnings per share. Hims & Hers Health’s revenue was up 77.1% compared to the same quarter last year. As a group, analysts predict that Hims & Hers Health will post 0.29 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Andrew Dudum sold 188,888 shares of Hims & Hers Health stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $20.88, for a total value of $3,943,981.44. Following the completion of the transaction, the chief executive officer now owns 67,015 shares in the company, valued at $1,399,273.20. The trade was a 73.81 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Anja Manuel purchased 4,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 12th. The stock was acquired at an average price of $26.94 per share, with a total value of $107,760.00. Following the purchase, the director now owns 4,000 shares in the company, valued at $107,760. This represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders sold a total of 1,333,446 shares of company stock valued at $34,175,197 in the last quarter. 17.71% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Hims & Hers Health

Several institutional investors and hedge funds have recently modified their holdings of the business. Quest Partners LLC increased its stake in Hims & Hers Health by 22.6% during the 3rd quarter. Quest Partners LLC now owns 4,373 shares of the company’s stock worth $81,000 after buying an additional 807 shares in the last quarter. CWM LLC increased its stake in Hims & Hers Health by 21.4% during the 3rd quarter. CWM LLC now owns 5,982 shares of the company’s stock worth $110,000 after buying an additional 1,054 shares in the last quarter. Arizona State Retirement System increased its stake in Hims & Hers Health by 3.0% during the 2nd quarter. Arizona State Retirement System now owns 40,344 shares of the company’s stock worth $815,000 after buying an additional 1,173 shares in the last quarter. Victory Capital Management Inc. increased its stake in Hims & Hers Health by 6.6% during the 2nd quarter. Victory Capital Management Inc. now owns 19,469 shares of the company’s stock worth $393,000 after buying an additional 1,212 shares in the last quarter. Finally, Rockefeller Capital Management L.P. increased its stake in Hims & Hers Health by 5.8% during the 3rd quarter. Rockefeller Capital Management L.P. now owns 33,775 shares of the company’s stock worth $622,000 after buying an additional 1,864 shares in the last quarter. Hedge funds and other institutional investors own 63.52% of the company’s stock.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.